| Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting D Viola, A Dona, E Caserta, E Troadec, F Besi, T McDonald, L Ghoda, ... Leukemia 35 (1), 189-200, 2021 | 65 | 2021 |
| Daratumumab induces CD38 internalization and impairs myeloma cell adhesion J Ghose, D Viola, C Terrazas, E Caserta, E Troadec, J Khalife, EG Gunes, ... Oncoimmunology 7 (10), e1486948, 2018 | 52 | 2018 |
| Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer X Cao, B Li, J Chen, J Dang, S Chen, EG Gunes, B Xu, L Tian, S Muend, ... Journal for ImmunoTherapy of Cancer 9 (3), 2021 | 49 | 2021 |
| MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages J Khalife, J Ghose, M Martella, D Viola, A Rocci, E Troadec, C Terrazas, ... JCI insight 4 (21), 2019 | 36 | 2019 |
| Strong association between lung cancer and the AXIN2 polymorphism EG Gunes, E Pinarbasi, H Pinarbasi, Y Silig Molecular medicine reports 2 (6), 1029-1035, 2009 | 35 | 2009 |
| CD84 is a regulator of the immunosuppressive microenvironment in Multiple Myeloma H Lewinsky, EG Gunes, K David, L Radomir, MP Kramer, B Pellegrino, ... JCI Insight, 2021 | 29 | 2021 |
| AXIN2 polymorphism and its association with prostate cancer in a Turkish population E Pinarbasi, EG Gunes, H Pinarbasi, G Donmez, Y Silig Medical oncology 28, 1373-1378, 2011 | 27 | 2011 |
| Targeting macrophages for enhancing CD47 blockade–elicited lymphoma clearance and overcoming tumor-induced immunosuppression X Cao, Y Wang, W Zhang, X Zhong, EG Gunes, J Dang, J Wang, ... Blood, The Journal of the American Society of Hematology 139 (22), 3290-3302, 2022 | 25 | 2022 |
| AXIN2 polymorphism and its association with astrocytoma in a Turkish population EG Gunes, E Pinarbasi, H Pinarbasi Molecular Medicine Reports 3 (4), 705-709, 2010 | 18 | 2010 |
| The role of myeloid-derived suppressor cells in hematologic malignancies EG Gunes, ST Rosen, C Querfeld Current opinion in oncology 32 (5), 518-526, 2020 | 17 | 2020 |
| Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting R Buettner, C Morales, E Caserta, E Troadec, EG Gunes, D Viola, ... Blood Advances 3 (7), 1027-1032, 2019 | 16 | 2019 |
| Immune mediated mechanisms of resistance to daratumumab D Viola, A Dona, EG Gunes, E Troadec, X Wu, S Branciamore, ... Blood 132, 3201, 2018 | 12 | 2018 |
| Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo J Ghose, A Dona, M Murtadha, EG Gunes, E Caserta, JY Yoo, L Russell, ... Molecular Therapy-Oncolytics 20, 519-531, 2021 | 9 | 2021 |
| The negative effect of antibiotics on RCC patients with immunotherapy: A systematic review and meta-analysis Z Luo, S Hao, Y Li, L Cheng, X Zhou, EG Gunes, S Liu, J Chen Frontiers in Immunology 13, 1065004, 2022 | 6 | 2022 |
| Glucocorticoid receptor expression in multiple myeloma patients is a predictor of survival A Pozhitkov, M Rosenzweig, F Pichiorri, EG Gunes, R Buettner, JJ Keats, ... Leukemia & Lymphoma, 2020 | 4 | 2020 |
| Tnfα promotes an immunosuppressive microenvironment in cutaneous T cell lymphoma and regulates PD-L1 expression EG Gunes, SH Kil, X Wu, C Su, Z Han, H Qin, TF He, J Chen, ... Blood 136, 33-34, 2020 | 2 | 2020 |
| Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors M Gunes, ST Rosen, I Shachar, EG Gunes Frontiers in Immunology 15, 1297473, 2024 | | 2024 |
| CD84 (SLAMF5) As a Potential Target for Immunomodulation in Cutaneous T-Cell Lymphoma (CTCL) M Gunes, ST Rosen, EG Gunes Blood 142, 4393, 2023 | | 2023 |
| The Role of Macrophage Migration Inhibitory Factor (MIF) in Regulation of T-Cell Activity in Multiple Myeloma M Gunes, ST Rosen, EG Gunes Blood 142, 4669, 2023 | | 2023 |
| Corrigendum: CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma (vol 6, e141683, 2021) H Lewinsky, EG Gunes, K David, L Radomir, MP Kramer, B Pellegrino, ... JCI insight 8 (14), 2023 | | 2023 |
